HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.

AbstractBACKGROUND:
Studies have shown that the classic acute-phase protein C-reactive protein (CRP) has proinflammatory effects on vascular cells and may play a causal role in the pathogenesis of coronary artery disease. A growing body of evidence has suggested that interplay between CRP, lectin-like oxidized LDL receptor-1 (LOX-1), and atherogenic LDL may underlie the mechanism of endothelial dysfunction that leads to atherosclerosis.
CONTENT:
We review the biochemical evidence for an association of CRP, LOX-1, and either oxidized LDL (OxLDL) or electronegative L5 LDL with the pathogenesis of coronary artery disease. Artificially oxidized OxLDL has been studied extensively for its role in atherogenesis, as has electronegative L5 LDL, which is present at increased levels in patients with increased cardiovascular risks. OxLDL and L5 have been shown to stimulate human aortic endothelial cells to produce CRP, indicating that CRP is synthesized locally in the endothelium. The ligand-binding face (B-face) of CRP has been shown to bind the LOX-1 scavenger receptor and increase LOX-1 expression in endothelial cells, thereby promoting the uptake of OxLDL or L5 by LOX-1 into endothelial cells to induce endothelial dysfunction.
SUMMARY:
CRP and LOX-1 may form a positive feedback loop with OxLDL or L5 in atherogenesis, whereby increased levels of atherogenic LDL in patients with cardiovascular risks induce endothelial cells to express CRP, which may in turn increase the expression of LOX-1 to promote the uptake of atherogenic LDL into endothelial cells. Further research is needed to confirm a causal role for CRP in atherogenesis.
AuthorsNicole Stancel, Chih-Chieh Chen, Liang-Yin Ke, Chih-Sheng Chu, Jonathan Lu, Tatsuya Sawamura, Chu-Huang Chen
JournalClinical chemistry (Clin Chem) Vol. 62 Issue 2 Pg. 320-7 (Feb 2016) ISSN: 1530-8561 [Electronic] England
PMID26607724 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Copyright© 2015 American Association for Clinical Chemistry.
Chemical References
  • Lipoproteins, LDL
  • OLR1 protein, human
  • Scavenger Receptors, Class E
  • low-density lipoprotein L5, human
  • oxidized low density lipoprotein
  • C-Reactive Protein
Topics
  • Aorta (metabolism)
  • Atherosclerosis (etiology, metabolism)
  • C-Reactive Protein (chemistry, metabolism)
  • Coronary Artery Disease (metabolism)
  • Endothelial Cells
  • Endothelium, Vascular (metabolism)
  • Humans
  • Lipoproteins, LDL (metabolism)
  • Macrophages (metabolism)
  • Scavenger Receptors, Class E (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: